Regeneron Pharmaceuticals | 流动资产



Current Assets 更改 日
AbbVie USD 25.58B 2.2B 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Astellas Pharma JPY 1.2T 2.56B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 32.74B 1.32B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Incyte USD 3.23B 7.24M 2025-03
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
J&J USD 55.89B 2.64B 2024-12
Kyowa Hakko Kirin JPY 450.23B 53.79B 2025-03
Merck USD 38.78B 1.58B 2024-12
Moderna USD 8.1B 1.57B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Regeneron Pharmaceuticals 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.